XVIVO: XVIVO Perfusion AB: Results from a Australian/New Zealand study using XVIVO's Heart Technology Published
GOTHENBURG, SE / ACCESSWIRE / November 3, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) The results of the clinical trial conducted in Australia and New Zealand on XVIVO's heart technolo...
Read full article »
XVIVO is a Sweden-based medical technology company that develops optimized solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation.
Read more